Related Articles

Recognizing National Latinx Aids Awareness Day

October 15, 2022 is National Latinx Aids Awareness Day (NLAAD). This observance calls for raising awareness on the impact of HIV on Hispanic/Latino/Latinx communities and eliminating stigma. NLAAD, first created by the by the Hispanic Federation and the Latino Commission on AIDS in 2003, is a good opportunity to feature the CDC’s Let’s Stop HIV Together …
The post Recognizing National Latinx Aids Awareness Day appeared first on Salud America.

FDA Approves New Drug for Alzheimer’s, But Scientists Divided Over Decision

The U.S. Food and Drug Administration approved a new drug called Aduhelm (aducanumab) to treat Alzheimer’s disease, the most common form of dementia. Many are applauding the drug and are encouraged by the scientific progress in a field that has long had limited treatment options. Alzheimer’s affects over 6.2 million people in the U.S., with …
The post FDA Approves New Drug for Alzheimer’s, But Scientists Divided Over Decision appeared first on Salud America.

Moderna Launches First Ever HIV Vaccine Clinical Trial

Forty years after the virus was discovered, an HIV vaccine is finally in development. Moderna and the International AIDS Vaccine Initiative (IAVI) are launching the first clinical trial for an HIV vaccine. “The search for an HIV vaccine has been long and challenging, and having new tools in terms of immunogens and platforms could be …
The post Moderna Launches First Ever HIV Vaccine Clinical Trial appeared first on Salud America.

The 1st Surgery for Alzheimer’s Disease in South Texas

A San Antonio woman in her 70s underwent South Texas’ first deep brain stimulation (DBS) surgery for Alzheimer’s — one of the first 300 surgeries of its kind in the world — at University Hospital on Nov. 5, 2021. UT Health San Antonio and clinical partner University Health are among 27 clinical trial sites worldwide …
The post The 1st Surgery for Alzheimer’s Disease in South Texas appeared first on Salud America.

Responses